IIB 

108TH CONGRESS 

1ST SESSION H. R. 2086

IN THE SENATE OF THE UNITED STATES 

OCTOBER 1, 2003

Received; read twice and referred to the Committee on the Judiciary 

AN ACT

To reauthorize the Office of National Drug Control Policy.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

HR 2086 RFS 

1 SECTION 1. SHORT TITLE; REFERENCES; TABLE OF CON2 TENTS. 

3 (a) SHORT TITLE.—This Act may be cited as the 

4 ‘‘Office of National Drug Control Policy Reauthorization 

5 Act of 2003’’. 

6 (b) AMENDMENT OF OFFICE OF NATIONAL DRUG

7 CONTROL POLICY REAUTHORIZATION ACT OF 1998.—Ex8 cept as otherwise expressly provided, whenever in this Act 

9 an amendment or repeal is expressed in terms of an 

10 amendment to, or repeal of, a section or other provision, 

11 the reference shall be considered to be made to a section 

12 or other provision of the Office of National Drug Control 

13 Policy Reauthorization Act of 1998 (Public Law 105–277; 

14 21 U.S.C. 1701 et seq.). 

15 (c) TABLE OF CONTENTS.—The table of contents of 

16 this Act is as follows:

Sec. 1. Short title; references; table of contents. 

Sec. 2. Amendments to definitions. 

Sec. 3. Amendments relating to appointment and duties of Director and Deputy Directors. 

Sec. 4. Amendments relating to coordination with other agencies. 

Sec. 5. Development, submission, implementation, and assessment of National 

Drug Control Strategy. 

Sec. 6. High intensity drug trafficking areas program. 

Sec. 7. Funding for certain high intensity drug trafficking areas. 

Sec. 8. Amendments relating to Counter-Drug Technology Assessment Center. 

Sec. 9. Repeals. 

Sec. 10. National Youth Antidrug Media Campaign. 

Sec. 11. Authorization of appropriations. 

Sec. 12. Extension of termination date.

17 SEC. 2. AMENDMENTS TO DEFINITIONS. 

18 (a) AMENDMENTS TO DEFINITIONS.—Section 702 

19 (21 U.S.C. 1701) is amended—
3

HR 2086 RFS 

1 (1) in paragraph (1)—

2 (A) by striking ‘‘and’’ at the end of sub3 paragraph (F); 

4 (B) by striking the period at the end of 

5 subparagraph (G) and inserting a semicolon; 

6 and 

7 (C) by adding at the end the following: 

8 ‘‘(H) interventions for drug abuse and de9 pendence; and 

10 ‘‘(I) international drug control coordina11 tion and cooperation with respect to activities 

12 described in this paragraph.’’. 

13 (2) in paragraph (9), by striking ‘‘implicates’’ 

14 and inserting ‘‘indicates’’; 

15 (3) in paragraph (10)—

16 (A) by striking ‘‘and’’ at the end of sub17 paragraph (B); 

18 (B) by striking the period at the end of 

19 subparagraph (C) and inserting ‘‘; and’’; and 

20 (C) by adding at the end the following: 

21 ‘‘(D) domestic drug law enforcement, in22 cluding law enforcement directed at drug 

23 users.’’; and 

24 (4) in paragraph (11)—
4

HR 2086 RFS 

1 (A) by inserting before the semicolon in 

2 subparagraph (A) the following: ‘‘(including 

3 source country programs, and law enforcement 

4 outside the United States)’’; 

5 (B) by inserting ‘‘and’’ after the semicolon 

6 in subparagraph (B); 

7 (C) by striking ‘‘; and’’ at the end of sub8 paragraph (C) and inserting a period; and 

9 (D) by striking subparagraph (D). 

10 (b) CONFORMING AMENDMENTS.—Section 703(b)(3) 

11 (21 U.S.C. 1702(b)(3)) is amended—

12 (1) in subparagraph (A), by striking ‘‘(G)’’ and 

13 inserting ‘‘(H)’’; and 

14 (2) in subparagraph (C)—

15 (A) by striking ‘‘(C)’’ and inserting ‘‘(D)’’; 

16 and 

17 (B) by striking ‘‘and subparagraph (D) of 

18 section 702(11)’’. 

19 SEC. 3. AMENDMENTS RELATING TO APPOINTMENT AND 

20 DUTIES OF DIRECTOR AND DEPUTY DIREC21 TORS. 

22 (a) DESIGNATION OF OTHER OFFICERS.—Section 

23 704(a)(3) (21 U.S.C. 1703(a)(3)) is amended—

24 (1) by striking ‘‘permanent employee’’ and in25 serting ‘‘officer or employee’’; and 
5

HR 2086 RFS 

1 (2) by striking ‘‘serve as the Director’’ and in2 serting ‘‘serve as the acting Director’’. 

3 (b) RESPONSIBILITIES OF DIRECTOR.—Section 

4 704(b) (21 U.S.C. 1703(b)) is amended—

5 (1) in paragraph (4), by striking ‘‘Federal de6 partments and agencies engaged in drug enforce7 ment,’’ and inserting ‘‘National Drug Control Pro8 gram agencies,’’; 

9 (2) by inserting ‘‘and’’ at the end of paragraph 

10 (12); 

11 (3) by striking paragraphs (13) and (14); and 

12 (4) by redesignating paragraph (15) as para13 graph (13). 

14 (c) REVIEW AND CERTIFICATION OF NATIONAL

15 DRUG CONTROL PROGRAM BUDGET.—Section 704(c)(3) 

16 (21 U.S.C. 1703(c)(3)) is amended—

17 (1) by redesignating subparagraphs (C) and 

18 (D) as subparagraphs (D) and (E), respectively; 

19 (2) by inserting after subparagraph (B) the fol20 lowing new subparagraph: 

21 ‘‘(C) SPECIFIC REQUESTS.—The Director 

22 shall not confirm the adequacy of any budget 

23 request that—

24 ‘‘(i) requests funding for Federal law 

25 enforcement activities that do not ade-
6

HR 2086 RFS 

1 quately compensate for transfers of drug 

2 enforcement resources and personnel to 

3 law enforcement and investigation activi4 ties not related to drug enforcement as de5 termined by the Director; 

6 ‘‘(ii) requests funding for law enforce7 ment activities on the borders of the 

8 United States that do not adequately di9 rect resources to drug interdiction and en10 forcement as determined by the Director; 

11 ‘‘(iii) requests funding for drug treat12 ment activities that do not provide ade13 quate result and accountability measures 

14 as determined by the Director; 

15 ‘‘(iv) requests funding for any activi16 ties of the Safe and Drug Free Schools 

17 Program that do not include a clear anti18 drug message or purpose intended to re19 duce drug use; 

20 ‘‘(v) requests funding to enforce sec21 tion 484(r)(1) of the Higher Education 

22 Act of 1965 (20 U.S.C. 1091(r)(1)) with 

23 respect to convictions for drug-related of24 fenses not occurring during a period of en25 rollment for which the student was receiv-
7

HR 2086 RFS 

1 ing any Federal grant, loan, or work as2 sistance; 

3 ‘‘(vi) requests funding for drug treat4 ment activities that do not adequately sup5 port and enhance Federal drug treatment 

6 programs and capacity, as determined by 

7 the Director; or 

8 ‘‘(vii) requests funding for fiscal year 

9 2005 for activities of the Department of 

10 Education, unless it is accompanied by a 

11 report setting forth a plan for providing 

12 expedited consideration of student loan ap13 plications for all individuals who submitted 

14 an application for any Federal grant, loan, 

15 or work assistance that was rejected or de16 nied pursuant to 484(r)(1) of the Higher 

17 Education Act of 1965 (20 U.S.C. 

18 1091(r)(1)) by reason of a conviction for a 

19 drug-related offense not occurring during a 

20 period of enrollment for which the indi21 vidual was receiving any Federal grant, 

22 loan, or work assistance.’’; 

23 (3) in subparagraph (D)(iii), as so redesig24 nated, by inserting ‘‘and the authorizing committees 
8

HR 2086 RFS 

1 of Congress for the Office’’ after ‘‘House of Rep2 resentatives’’; and 

3 (4) in subparagraph (E)(ii)(bb), as so redesig4 nated, by inserting ‘‘and the authorizing committees 

5 of Congress for the Office’’ after ‘‘House of Rep6 resentatives’’. 

7 (d) REPROGRAMMING AND TRANSFER REQUESTS.—

8 Section 704(c)(4)(A) (21 U.S.C. 1703(c)(4)(A)) is amend9 ed by striking ‘‘$5,000,000’’ and inserting ‘‘$1,000,000’’. 

10 (e) POWERS OF DIRECTOR.—Section 704(d) (21 

11 U.S.C. 1703(d)) is amended—

12 (1) in paragraph (8)(D), by striking ‘‘have been 

13 authorized by Congress;’’ and inserting ‘‘authorized 

14 by law;’’; 

15 (2) in paragraph (9)—

16 (A) by inserting ‘‘notwithstanding any 

17 other provision of law,’’ after ‘‘(9)’’; and 

18 (B) by striking ‘‘Strategy; and’’ and insert19 ing ‘‘Strategy and notify the authorizing Com20 mittees of Congress for the Office of any fund 

21 control notice issued;’’; 

22 (3) in paragraph (10), by striking ‘‘(22 U.S.C. 

23 2291j).’’ and inserting ‘‘(22 U.S.C. 2291j) and sec24 tion 706 of the Department of State Authorization 

25 Act for Fiscal Year 2003 (22 U.S.C. 229j–l);’’; 
9

HR 2086 RFS 

1 (4) by adding at the end the following new 

2 paragraphs: 

3 ‘‘(11) not later than August 1 of each year, 

4 submit to the President a report, and transmit cop5 ies of the report to the Secretary of State and the 

6 authorizing Committees of Congress for the Office, 

7 that—

8 ‘‘(A) provides the Director’s assessment of 

9 which countries are major drug transit coun10 tries or major illicit drug producing countries as 

11 defined in section 481(e) of the Foreign Assist12 ance Act of 1961; 

13 ‘‘(B) provides the Director’s assessment of 

14 whether each country identified under subpara15 graph (A) has cooperated fully with the United 

16 States or has taken adequate steps on its own 

17 to achieve full compliance with the goals and 

18 objectives established by the United Nations 

19 Convention Against Illicit Traffic in Narcotic 

20 Drugs and Psychotropic Substances and other21 wise has assisted in reducing the supply of il22 licit drugs to the United States; and 

23 ‘‘(C) provides the Director’s assessment of 

24 whether application of procedures set forth in 

25 section 490(a) through (h) of the Foreign As-
10

HR 2086 RFS 

1 sistance Act of 1961, as provided in section 706 

2 of the Department of State Authorization Act 

3 for Fiscal Year 2003, is warranted with respect 

4 to countries the Director assesses have not co5 operated fully; and 

6 ‘‘(12) appoint a United States Interdiction Co7 ordinator under subsection (i).’’. 

8 (f) UNITED STATES INTERDICTION COORDINATOR.—

9 Section 704 (21 U.S.C. 1703) is further amended by add10 ing at the end the following: 

11 ‘‘(i) UNITED STATES INTERDICTION COORDI12 NATOR.—

13 ‘‘(1) IN GENERAL.—There shall be in the Office 

14 a United States Interdiction Coordinator, who shall 

15 be appointed by the Director and shall perform du16 ties determined by the Director with respect to co17 ordination of efforts to interdict illicit drugs from 

18 the United States. 

19 ‘‘(2) APPOINTMENT.—

20 ‘‘(A) IN GENERAL.—Notwithstanding any 

21 other provision of law (except subparagraph 

22 (B)), the Director may appoint any individual 

23 to serve as the United States Interdiction Coor24 dinator. 
11

HR 2086 RFS 

1 ‘‘(B) LIMITATION.—The Director may not 

2 appoint to such position any individual who 

3 concurrently serves as the head of any other 

4 Federal department or agency or any subdivi5 sion thereof with responsibility for narcotics 

6 interdiction activities, except the counter7 narcotics officer of the Department of Home8 land Security appointed under section 878 of 

9 the Homeland Security Act of 2002 (6 U.S.C. 

10 458).’’. 

11 (g) REQUIREMENT FOR SOUTH AMERICAN HEROIN

12 STRATEGY.—

13 (1) IN GENERAL.—Not later than 90 days after 

14 the date of the enactment of this Act, the Director 

15 of National Drug Control Policy shall submit to the 

16 Congress a comprehensive strategy that addresses 

17 the increased threat from South American heroin, 

18 and in particular Colombian heroin. 

19 (2) CONTENTS.—The strategy shall—

20 (A) include opium eradication efforts to 

21 eliminate the problem at the source to prevent 

22 it from reoccurring before the heroin enters the 

23 stream of commerce; 

24 (B) interdiction and precursor chemical 

25 controls; 
12

HR 2086 RFS 

1 (C) demand reduction and treatment; 

2 (D) provisions that ensure the mainte3 nance at current levels of efforts to eradicate 

4 coca in Colombia; and 

5 (E) assessment of the level of additional 

6 funding and resources necessary to simulta7 neously address the threat from South Amer8 ican heroin and the threat from Colombian 

9 coca. 

10 SEC. 4. AMENDMENTS RELATING TO COORDINATION WITH 

11 OTHER AGENCIES. 

12 Section 705 (21 U.S.C. 1704) is amended—

13 (1) in subsection (a)(1)(A), by striking 

14 ‘‘abuse’’; 

15 (2) by amending paragraph (3) of subsection 

16 (a) to read as follows: 

17 ‘‘(3) REQUIRED REPORTS.—

18 ‘‘(A) SECRETARIES OF THE INTERIOR AND

19 AGRICULTURE.—The Secretaries of Agriculture 

20 and Interior shall, by July 1 of each year, joint21 ly submit to the Director and the authorizing 

22 Committees of Congress for the Office an as23 sessment of the quantity of illegal drug cultiva24 tion and manufacturing in the United States on 
13

HR 2086 RFS 

1 lands owned or under the jurisdiction of the 

2 Federal Government for the preceding year. 

3 ‘‘(B) ATTORNEY GENERAL.—The Attorney 

4 General shall, by July 1 of each year, submit to 

5 the Director and the authorizing Committees of 

6 Congress for the Office information for the pre7 ceding year regarding the number and type 

8 of—

9 ‘‘(i) arrests for drug violations; 

10 ‘‘(ii) prosecutions for drug violations 

11 by United States Attorneys; and 

12 ‘‘(iii) the number and type of seizures 

13 of drugs by each component of the Depart14 ment seizing drugs, as well as statistical 

15 information on the geographic areas of 

16 such seizures. 

17 ‘‘(C) SECRETARY OF HOMELAND SECU18 RITY.—The Secretary of Homeland Security 

19 shall, by July 1 of each year, submit to the Di20 rector and the authorizing Committees of Con21 gress for the Office information for the pre22 ceding year regarding—

23 ‘‘(i) the number and type of seizures 

24 of drugs by each component of the Depart25 ment seizing drugs, as well as statistical 
14

HR 2086 RFS 

1 information on the geographic areas of 

2 such seizures; and 

3 ‘‘(ii) the number of air and maritime 

4 patrol hours undertaken by each compo5 nent of the Department primarily dedi6 cated to drug supply reduction missions. 

7 ‘‘(D) SECRETARY OF DEFENSE.—The Sec8 retary of Defense shall, by July 1 of each year, 

9 submit to the Director and the authorizing 

10 Committees of Congress for the Office informa11 tion for the preceding year regarding the num12 ber of air and maritime patrol hours primarily 

13 dedicated to drug supply reduction missions un14 dertaken by each component of the Department 

15 of Defense.’’; and 

16 (3) in subsection (b)(2)(B), by striking ‘‘Pro17 gram.’’ and inserting ‘‘Strategy.’’. 

18 SEC. 5. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 

19 AND ASSESSMENT OF NATIONAL DRUG CON20 TROL STRATEGY. 

21 Section 706 (21 U.S.C. 1705) is amended to read as 

22 follows: 
15

HR 2086 RFS 

1 ‘‘SEC. 706. DEVELOPMENT, SUBMISSION, IMPLEMENTATION, 

2 AND ASSESSMENT OF NATIONAL DRUG CON3 TROL STRATEGY. 

4 ‘‘(a) TIMING, CONTENTS, AND PROCESS FOR DEVEL5 OPMENT AND SUBMISSION OF NATIONAL DRUG CONTROL

6 STRATEGY.—

7 ‘‘(1) IN GENERAL.—Not later than February 1 

8 of each year, the President shall submit to Congress 

9 a National Drug Control Strategy, which shall set 

10 forth a comprehensive plan for reducing illicit drug 

11 use and the consequences of illicit drug use in the 

12 United States by reducing the demand for illegal 

13 drugs, limiting the availability of illegal drugs, and 

14 conducting law enforcement activities with respect to 

15 illegal drugs. 

16 ‘‘(2) CONTENTS.— 

17 ‘‘(A) IN GENERAL.—The National Drug 

18 Control Strategy submitted under paragraph 

19 (1) shall include—

20 ‘‘(i) comprehensive, research-based, 

21 long-range, and quantifiable goals for re22 ducing illicit drug use and the con23 sequences of illicit drug use in the United 

24 States; 

25 ‘‘(ii) annual objectives and strategy 

26 for demand reduction, supply reduction, 
16

HR 2086 RFS 

1 and law enforcement activities, specific tar2 gets to accomplish long-range quantifiable 

3 reduction in illicit drug use as determined 

4 by the Director, and specific measurements 

5 to evaluate progress toward the targets 

6 and strategic goals; 

7 ‘‘(iii) a strategy to reduce the avail8 ability and purity of illegal drugs and the 

9 level of drug-related crime in the United 

10 States; 

11 ‘‘(iv) an assessment of Federal effec12 tiveness in achieving the National Drug 

13 Control Strategy for the previous year, in14 cluding—

15 ‘‘(I) a specific evaluation of 

16 whether the objectives and targets for 

17 reducing illicit drug use for the pre18 vious year were met and reasons for 

19 the success or failure of the previous 

20 year’s Strategy; and 

21 ‘‘(II) an assessment of the avail22 ability and purity of illegal drugs and 

23 the level of drug-related crime in the 

24 United States; 
17

HR 2086 RFS 

1 ‘‘(v) notification of any program or 

2 budget priorities that the Director expects 

3 to significantly change from the current 

4 Strategy over the next five years; 

5 ‘‘(vi) a review of international, State, 

6 local, and private sector drug control ac7 tivities to ensure that the United States 

8 pursues well-coordinated and effective drug 

9 control at all levels of government; 

10 ‘‘(vii) such statistical data and infor11 mation as the Director deems appropriate 

12 to demonstrate and assess trends relating 

13 to illicit drug use, the effects and con14 sequences thereof, supply reduction, de15 mand reduction, drug-related law enforce16 ment, and the implementation of the Na17 tional Drug Control Strategy; and 

18 ‘‘(viii) a supplement reviewing the ac19 tivities of each individual National Drug 

20 Control Program agency during the pre21 vious year with respect to the National 

22 Drug Control Strategy and the Director’s 

23 assessment of the progress of each Na24 tional Drug Control Program agency in 
18

HR 2086 RFS 

1 meeting its responsibilities under the Na2 tional Drug Control Strategy. 

3 ‘‘(B) CLASSIFIED INFORMATION.—Any 

4 contents of the National Drug Control Strategy 

5 that involve information properly classified 

6 under criteria established by an Executive order 

7 shall be presented to Congress separately from 

8 the rest of the National Drug Control Strategy. 

9 ‘‘(C) SELECTION OF DATA AND INFORMA10 TION.—In selecting data and information for 

11 inclusion under subparagraph (A), the Director 

12 shall ensure—

13 ‘‘(i) the inclusion of data and informa14 tion that will permit analysis of current 

15 trends against previously compiled data 

16 and information where the Director be17 lieves such analysis enhances long-term as18 sessment of the National Drug Control 

19 Strategy; and 

20 ‘‘(ii) the inclusion of data and infor21 mation to permit a standardized and uni22 form assessment of the effectiveness of 

23 drug treatment programs in the United 

24 States. 
19

HR 2086 RFS 

1 ‘‘(3) PROCESS FOR DEVELOPMENT AND SUB2 MISSION.—

3 ‘‘(A) CONSULTATION.—In developing and 

4 effectively implementing the National Drug 

5 Control Strategy, the Director—

6 ‘‘(i) shall consult with—

7 ‘‘(I) the heads of the National 

8 Drug Control Program agencies; 

9 ‘‘(II) Congress; 

10 ‘‘(III) State and local officials; 

11 ‘‘(IV) private citizens and organi12 zations with experience and expertise 

13 in demand reduction; 

14 ‘‘(V) private citizens and organi15 zations with experience and expertise 

16 in supply reduction; 

17 ‘‘(VI) private citizens and organi18 zations with experience and expertise 

19 in law enforcement; and 

20 ‘‘(VII) appropriate representa21 tives of foreign governments; 

22 ‘‘(ii) with the concurrence of the At23 torney General, may require the El Paso 

24 Intelligence Center to undertake specific 
20

HR 2086 RFS 

1 tasks or projects to implement the Na2 tional Drug Control Strategy; 

3 ‘‘(iii) with the concurrence of the Di4 rector of Central Intelligence and the At5 torney General, may request that the Na6 tional Drug Intelligence Center undertake 

7 specific tasks or projects to implement the 

8 National Drug Control Strategy; and 

9 ‘‘(iv) may make recommendations to 

10 the Secretary of Health and Human Serv11 ices on research that supports or advances 

12 the National Drug Control Strategy. 

13 ‘‘(B) RECOMMENDATIONS.—Recommenda14 tions under subparagraph (A)(iv) may include 

15 recommendations of research to be performed 

16 at the National Institutes of Health, including 

17 the National Institute on Drug Abuse, or any 

18 other appropriate agency within the Depart19 ment of Health and Human Services. 

20 ‘‘(C) INCLUSION IN STRATEGY.—The Na21 tional Drug Control Strategy under this sub22 section shall include a list of each entity con23 sulted under subparagraph (A)(i). 

24 ‘‘(4) SUBMISSION OF REVISED STRATEGY.—The 

25 President may submit to Congress a revised Na-
21

HR 2086 RFS 

1 tional Drug Control Strategy that meets the require2 ments of this section—

3 ‘‘(A) at any time, upon a determination by 

4 the President, in consultation with the Director, 

5 that the National Drug Control Strategy in ef6 fect is not sufficiently effective; or 

7 ‘‘(B) if a new President or Director takes 

8 office. 

9 ‘‘(b) PERFORMANCE MEASUREMENT SYSTEM.—Not 

10 later than February 1 of each year, the Director shall sub11 mit to Congress a description of the national drug control 

12 performance measurement system, designed in consulta13 tion with affected National Drug Control Program agen14 cies, that includes performance measures for the National 

15 Drug Control Strategy and activities of National Drug 

16 Control Program agencies related to the National Drug 

17 Control Strategy.’’. 

18 SEC. 6. HIGH INTENSITY DRUG TRAFFICKING AREAS PRO19 GRAM. 

20 (a) IN GENERAL.—Section 707 (21 U.S.C. 1706) is 

21 amended to read as follows: 

22 ‘‘SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS 

23 PROGRAM. 

24 ‘‘(a) ESTABLISHMENT.—There is established in the 

25 Office a program to be known as the High Intensity Drug 
22

HR 2086 RFS 

1 Trafficking Areas Program (in this section referred to as 

2 the ‘Program’). 

3 ‘‘(b) PURPOSES.—The purposes of the Program are 

4 the following: 

5 ‘‘(1) To reduce drug availability and facilitate 

6 cooperative efforts between Federal, State, and local 

7 law enforcement agencies in areas with significant 

8 drug trafficking problems that harmfully impact 

9 other parts of the Nation. 

10 ‘‘(2) To provide assistance to agencies to come 

11 together to assess regional threats, design coordi12 nated strategies to combat those threats, share intel13 ligence, and develop and implement coordinated ini14 tiatives to implement the strategies. 

15 ‘‘(c) DESIGNATION.—The Director, upon consulta16 tion with the Attorney General, the Secretary of the 

17 Treasury, the Secretary of Homeland Security, heads of 

18 the National Drug Control Program agencies, and the 

19 Governor of each applicable State, may designate any 

20 specified area of the United States as a high intensity 

21 drug trafficking area. 

22 ‘‘(d) FACTORS FOR CONSIDERATION.—

23 ‘‘(1) IN GENERAL.—In considering whether to 

24 designate an area under this section as a high inten25 sity drug trafficking area, the Director shall con-
23

HR 2086 RFS 

1 sider, in addition to such other criteria as the Direc2 tor considers to be appropriate, the extent to 

3 which—

4 ‘‘(A) the area is a major center of illegal 

5 drug production, manufacturing, importation, 

6 or distribution for the United States as com7 pared to other areas of the United States; 

8 ‘‘(B) State and local law enforcement 

9 agencies have committed resources to respond 

10 to the drug trafficking problem in the area, 

11 thereby indicating a determination to respond 

12 aggressively to the problem; 

13 ‘‘(C) drug production, manufacturing, im14 portation, or distribution in the area is having 

15 a significant harmful impact in other areas of 

16 the United States; and 

17 ‘‘(D) a significant increase in allocation of 

18 Federal resources is necessary to respond ade19 quately to drug-related activities in the area. 

20 ‘‘(2) CONSIDERATIONS.—For purposes of para21 graph (1)(A), in considering whether an area is a 

22 major center of illegal drug production, manufac23 turing, importation, or distribution as compared to 

24 other areas of the United States, the Director shall 

25 consider—
24

HR 2086 RFS 

1 ‘‘(A) the quantity of illicit drug traffic en2 tering or transiting the area originating in for3 eign countries; 

4 ‘‘(B) the quantity of illicit drugs produced 

5 in the area; 

6 ‘‘(C) the number of Federal, State, and 

7 local arrests, prosecutions, and convictions for 

8 drug trafficking and distribution offenses in the 

9 area; 

10 ‘‘(D) the degree to which the area is a cen11 ter for the activities of national drug trafficking 

12 organizations; and 

13 ‘‘(E) such other criteria as the Director 

14 considers appropriate. 

15 ‘‘(e) SOUTHWEST BORDER.—The Director may not 

16 designate any county contiguous to the international land 

17 border with Mexico as part of any high intensity drug traf18 ficking area other than as part of a single Southwest Bor19 der high intensity drug trafficking area. 

20 ‘‘(f) REMOVAL FROM DESIGNATION.—The Director 

21 may remove an area or portion of an area from designa22 tion as a high intensity drug trafficking area under this 

23 section upon determination that the area or portion of an 

24 area no longer is a high intensity drug trafficking area, 

25 considering the factors in subsections (d) and (e) in addi-
25

HR 2086 RFS 

1 tion to such other criteria as the Director considers to be 

2 appropriate. 

3 ‘‘(g) AUTHORITY OF THE DIRECTOR.—After making 

4 such a designation and in order to provide Federal assist5 ance to the area so designated, the Director may—

6 ‘‘(1) obligate such sums as appropriated for the 

7 Program, in accordance with subsection (h); 

8 ‘‘(2) direct the temporary reassignment of Fed9 eral personnel to such area, subject to the approval 

10 of the head of the department or agency that em11 ploys such personnel; and 

12 ‘‘(3) take any other action authorized under 

13 section 704 to provide increased Federal assistance 

14 to those areas. 

15 ‘‘(h) ALLOCATION OF FUNDING.—In obligating sums 

16 appropriated for the Program, the Director shall comply 

17 with the following: 

18 ‘‘(1) 30 PERCENT SET ASIDE.—The Director 

19 shall expend no less than 30 percent of the amounts 

20 appropriated under this section in the seven high in21 tensity drug trafficking areas (excluding the South22 west Border high intensity drug trafficking area) for 

23 which the Director determines that Program activi24 ties with respect to such areas will have the greatest 
26

HR 2086 RFS 

1 impact on reducing overall drug traffic in the United 

2 States. 

3 ‘‘(2) 25 PERCENT SET ASIDE.—The Director 

4 shall expend no less than 25 percent of the amounts 

5 appropriated under this section in nine other high 

6 intensity drug trafficking areas (excluding the 

7 Southwest Border high intensity drug trafficking 

8 area) for which the Director determines that Pro9 gram activities with respect to such areas will have 

10 the next greatest impact on reducing overall drug 

11 traffic in the United States. 

12 ‘‘(3) SOUTHWEST BORDER AREA.—

13 ‘‘(A) 20 PERCENT SET ASIDE.—The Direc14 tor shall expend no less than 20 percent of the 

15 amounts appropriated under this section in the 

16 Southwest Border high intensity drug traf17 ficking area. 

18 ‘‘(B) REALLOCATION WITHIN AREA.—The 

19 executive committee of the Southwest Border 

20 high intensity drug trafficking area may reallo21 cate up to five percent of the total funds allo22 cated to that area among its components, with 

23 the approval of the Director. 

24 ‘‘(4) REMAINING AREAS.—The Director shall 

25 expend no less than 10 percent of the amounts ap-
27

HR 2086 RFS 

1 propriated under this section in the remaining high 

2 intensity drug trafficking areas. 

3 ‘‘(5) DISCRETIONARY EXPENDITURES.—

4 ‘‘(A) IN GENERAL.—In addition to the 

5 amounts allocated under paragraphs (1) 

6 through (4) the Director may expend 15 per7 cent of the amounts appropriated under this 

8 section on a discretionary basis. 

9 ‘‘(B) CONSIDERATION OF IMPACT.—In al10 locating funds under this paragraph, the Direc11 tor shall consider—

12 ‘‘(i) the impact of activities funded on 

13 reducing overall drug traffic in the United 

14 States; 

15 ‘‘(ii) performance measures of effec16 tiveness; and 

17 ‘‘(iii) such other criteria as the Direc18 tor considers appropriate. 

19 ‘‘(i) USE OF FUNDS.—

20 ‘‘(1) LIMITATION.—No funds appropriated for 

21 the Program shall be expended for drug treatment 

22 programs. 

23 ‘‘(2) LIMITATION ON APPLICABILITY.—Para24 graph (1) shall not apply with respect to the 
28

HR 2086 RFS 

1 Baltimore/Washington high intensity drug traf2 ficking area. 

3 ‘‘(j) TERRORISM ACTIVITIES.—

4 ‘‘(1) ASSISTANCE AUTHORIZED.—The Director 

5 may authorize use of resources available for the Pro6 gram to assist Federal, State, and local law enforce7 ment agencies in investigations and activities related 

8 to terrorism and prevention of terrorism, especially 

9 but not exclusively where such investigations are re10 lated to drug trafficking. 

11 ‘‘(2) LIMITATION.—The Director shall ensure—

12 ‘‘(A) that assistance provided under para13 graph (1) remains incidental to the purpose of 

14 the Program to reduce drug availability and 

15 carry out drug-related law enforcement activi16 ties; and 

17 ‘‘(B) that significant resources of the Pro18 gram are not redirected to activities exclusively 

19 related to terrorism. 

20 ‘‘(k) BOARD REPRESENTATION.—None of the funds 

21 appropriated under this section may be expended for any 

22 high intensity drug trafficking area, or for a partnership 

23 under the Program, if the executive board or equivalent 

24 governing committee with respect to such area or partner25 ship is not comprised of equal voting representation be-
29

HR 2086 RFS 

1 tween representatives of Federal law enforcement agencies 

2 and representatives of State and local law enforcement 

3 agencies. 

4 ‘‘(l) ROLE OF DRUG ENFORCEMENT ADMINISTRA5 TION.—The Director, in consultation with the Attorney 

6 General, shall ensure that a representative of the Drug 

7 Enforcement Administration is included in the Intelligence 

8 Support Center for each high intensity drug trafficking 

9 area. 

10 ‘‘(m) AUTHORIZATION OF APPROPRIATIONS.—There 

11 is authorized to be appropriated to the Office of National 

12 Drug Control Policy to carry out this section—

13 ‘‘(1) $230,000,000 for fiscal year 2004; 

14 ‘‘(2) $240,000,000 for each of fiscal years 2005 

15 and 2006; and 

16 ‘‘(3) $250,000,000 for each of fiscal years 2007 

17 and 2008.’’. 

18 (b) REVIEW OF CURRENT AREAS.—Within one year 

19 after the date of enactment of this Act, the Director of 

20 National Drug Control Policy shall—

21 (1) review each of the areas currently des22 ignated as a high intensity drug trafficking area to 

23 determine whether it continues to warrant designa24 tion as a high intensity drug trafficking area, con25 sidering the factors in section 707(d) of the Office 
30

HR 2086 RFS 

1 of National Drug Control Policy Reauthorization Act 

2 of 1998, as amended by this section, in addition to 

3 such other criteria as the Director considers to be 

4 appropriate; and 

5 (2) terminate such description for an area or 

6 portion of an area determined to no longer warrant 

7 designation. 

8 SEC. 7. FUNDING FOR CERTAIN HIGH INTENSITY DRUG 

9 TRAFFICKING AREAS. 

10 (a) SHORT TITLE.—This section may be cited as the 

11 ‘‘Dawson Family Community Protection Act’’. 

12 (b) FINDINGS.—Congress finds the following: 

13 (1) In the early morning hours of October 16, 

14 2002, the home of Carnell and Angela Dawson was 

15 firebombed in apparent retaliation for Mrs. 

16 Dawson’s notification of police about persistent drug 

17 distribution activity in their East Baltimore City 

18 neighborhood. 

19 (2) The arson claimed the lives of Mr. and Mrs. 

20 Dawson and their 5 young children, aged 9 to 14. 

21 (3) The horrific murder of the Dawson family 

22 is a stark example of domestic narco-terrorism. 

23 (4) In all phases of counter-narcotics law en24 forcement—from prevention to investigation to pros-
31

HR 2086 RFS 

1 ecution to reentry—the voluntary cooperation of or2 dinary citizens is a critical component. 

3 (5) Voluntary cooperation is difficult for law en4 forcement officials to obtain when citizens feel that 

5 cooperation carries the risk of violent retaliation by 

6 illegal drug trafficking organizations and their affili7 ates. 

8 (6) Public confidence that law enforcement is 

9 doing all it can to make communities safe is a pre10 requisite for voluntary cooperation among people 

11 who may be subject to intimidation or reprisal (or 

12 both). 

13 (7) Witness protection programs are insufficient 

14 on their own to provide security because many indi15 viduals and families who strive every day to make 

16 distressed neighborhoods livable for their children, 

17 other relatives, and neighbors will resist or refuse of18 fers of relocation by local, State, and Federal pros19 ecutorial agencies and because, moreover, the contin20 ued presence of strong individuals and families is 

21 critical to preserving and strengthening the social 

22 fabric in such communities. 

23 (8) Where (as in certain sections of Baltimore 

24 City) interstate trafficking of illegal drugs has severe 

25 ancillary local consequences within areas designated 
32

HR 2086 RFS 

1 as high intensity drug trafficking areas, it is impor2 tant that supplementary High Intensity Drug Traf3 ficking Areas Program funds be committed to sup4 port initiatives aimed at making the affected com5 munities safe for the residents of those communities 

6 and encouraging their cooperation with local, State, 

7 and Federal law enforcement efforts to combat ille8 gal drug trafficking. 

9 (c) FUNDING FOR CERTAIN HIGH INTENSITY DRUG

10 TRAFFICKING AREAS.—Section 707 (21 U.S.C. 1706) is 

11 further amended in subsection (h) by adding at the end 

12 the following new paragraph: 

13 ‘‘(6) SPECIFIC PURPOSES.—

14 ‘‘(A) IN GENERAL.—The Director shall en15 sure that, of the amounts appropriated for a 

16 fiscal year for the Program, at least $1,000,000 

17 is used in high intensity drug trafficking areas 

18 with severe neighborhood safety and illegal drug 

19 distribution problems. 

20 ‘‘(B) REQUIRED USES.—The funds used 

21 under subparagraph (A) shall be used—

22 ‘‘(i) to ensure the safety of neighbor23 hoods and the protection of communities, 

24 including the prevention of the intimida-
33

HR 2086 RFS 

1 tion of potential witnesses of illegal drug 

2 distribution and related activities; and 

3 ‘‘(ii) to combat illegal drug trafficking 

4 through such methods as the Director con5 siders appropriate, such as establishing or 

6 operating (or both) a toll-free telephone 

7 hotline for use by the public to provide in8 formation about illegal drug-related activi9 ties.’’. 

10 SEC. 8. AMENDMENTS RELATING TO COUNTER-DRUG TECH11 NOLOGY ASSESSMENT CENTER. 

12 (a) CHIEF SCIENTIST.—Section 708(b) (21 U.S.C. 

13 1707(b)) is amended—

14 (1) in the heading by striking ‘‘DIRECTOR OF

15 TECHNOLOGY.—’’ and inserting ‘‘CHIEF SCI16 ENTIST.—’’; and 

17 (2) by striking ‘‘Director of Technology,’’ and 

18 inserting ‘‘Chief Scientist,’’. 

19 (b) ADDITIONAL RESPONSIBILITIES OF DIRECTOR.—

20 Section 708(c) (21 U.S.C. 1707(c)) is amended to read 

21 as follows: 

22 ‘‘(c) ADDITIONAL RESPONSIBILITIES OF THE DIREC23 TOR OF NATIONAL DRUG CONTROL POLICY.—

24 ‘‘(1) IN GENERAL.—The Director, acting 

25 through the Chief Scientist shall—
34

HR 2086 RFS 

1 ‘‘(A) identify and define the short-, me2 dium-, and long-term scientific and techno3 logical needs of Federal, State, and local law 

4 enforcement agencies relating to drug enforce5 ment, including—

6 ‘‘(i) advanced surveillance, tracking, 

7 and radar imaging; 

8 ‘‘(ii) electronic support measures; 

9 ‘‘(iii) communications; 

10 ‘‘(iv) data fusion, advanced computer 

11 systems, and artificial intelligence; and 

12 ‘‘(v) chemical, biological, radiological 

13 (including neutron, electron, and graviton), 

14 and other means of detection; 

15 ‘‘(B) identify demand reduction (including 

16 drug prevention) basic and applied research 

17 needs and initiatives, in consultation with af18 fected National Drug Control Program agen19 cies, including—

20 ‘‘(i) improving treatment through 

21 neuroscientific advances; 

22 ‘‘(ii) improving the transfer of bio23 medical research to the clinical setting; and 

24 ‘‘(iii) in consultation with the Na25 tional Institute on Drug Abuse and the 
35

HR 2086 RFS 

1 Substance Abuse and Mental Health Serv2 ices Administration, and through inter3 agency agreements or grants, examining 

4 addiction and rehabilitation research and 

5 the application of technology to expanding 

6 the effectiveness or availability of drug 

7 treatment; 

8 ‘‘(C) make a priority ranking of such needs 

9 identified in subparagraphs (A) and (B) accord10 ing to fiscal and technological feasibility, as 

11 part of a National Counter-Drug Enforcement 

12 Research and Development Program; 

13 ‘‘(D) oversee and coordinate counter-drug 

14 technology initiatives with related activities of 

15 other Federal civilian and military departments; 

16 ‘‘(E) oversee and coordinate a technology 

17 transfer program for the transfer of technology 

18 to State and local law enforcement agencies; 

19 and 

20 ‘‘(F) pursuant to the authority of the Di21 rector of National Drug Control Policy under 

22 section 704, submit requests to Congress for 

23 the reprogramming or transfer of funds appro24 priated for counter-drug technology research 

25 and development. 
36

HR 2086 RFS 

1 ‘‘(2) PRIORITIES IN TRANSFERRING TECH2 NOLOGY.—In transferring technology under the au3 thority of paragraph (1)(E), the Chief Scientist shall 

4 give priority, in transferring technologies most likely 

5 to assist in drug interdiction and border enforce6 ment, to State, local, and tribal law enforcement 

7 agencies in southwest border areas and northern 

8 border areas with significant traffic in illicit drugs. 

9 ‘‘(3) LIMITATION ON AUTHORITY.—The author10 ity granted to the Director under this subsection 

11 shall not extend to the award of contracts, manage12 ment of individual projects, or other operational ac13 tivities.’’. 

14 (c) ASSISTANCE FROM SECRETARY OF HOMELAND

15 SECURITY.—Section 708(d) (21 U.S.C. 1707(d)) is 

16 amended by inserting ‘‘, the Secretary of Homeland Secu17 rity,’’ after ‘‘The Secretary of Defense’’. 

18 SEC. 9. REPEALS. 

19 The following provisions are repealed: 

20 (1) Sections 709 and 711 (21 U.S.C. 1708 and 

21 1710). 

22 (2) Section 6073 of the Asset Forfeiture 

23 Amendments Act of 1988 (21 U.S.C. 1509). 
37

HR 2086 RFS 

1 SEC. 10. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN. 

2 (a) IN GENERAL.—The Act is further amended by 

3 inserting after section 708 the following: 

4 ‘‘SEC. 709. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN. 

5 ‘‘(a) IN GENERAL.—The Director shall conduct a na6 tional media campaign in accordance with this section for 

7 the purpose of reducing and preventing illicit drug use 

8 among young people in the United States, through mass 

9 media advertising. 

10 ‘‘(b) USE OF FUNDS.—

11 ‘‘(1) IN GENERAL.—Amounts made available to 

12 carry out this section for the media campaign may 

13 only be used for the following: 

14 ‘‘(A) The purchase of media time and 

15 space. 

16 ‘‘(B) Creative and talent costs. 

17 ‘‘(C) Advertising production costs. 

18 ‘‘(D) Testing and evaluation of advertising. 

19 ‘‘(E) Evaluation of the effectiveness of the 

20 media campaign. 

21 ‘‘(F) The negotiated fees for the winning 

22 bidder on requests for proposals issued either 

23 by the Office or its designee for purposes other24 wise authorized in this section. 
38

HR 2086 RFS 

1 ‘‘(G) Partnerships with community, civic, 

2 and professional groups and government organi3 zations related to the media campaign. 

4 ‘‘(H) Entertainment industry outreach, 

5 interactive outreach, media projects and activi6 ties, public information, news media outreach, 

7 and corporate sponsorship and participation. 

8 ‘‘(I) Operational and management ex9 penses. 

10 ‘‘(2) SPECIFIC REQUIREMENTS.—

11 ‘‘(A) CREATIVE SERVICES.—

12 ‘‘(i) In using amounts for creative and 

13 talent costs under paragraph (1)(B), the 

14 Director shall use creative services donated 

15 at no cost to the Government wherever fea16 sible and may only procure creative serv17 ices for advertising—

18 ‘‘(I) responding to high-priority 

19 or emergent campaign needs that can20 not timely be obtained at no cost; or 

21 ‘‘(II) intended to reach a minor22 ity, ethnic, or other special audience 

23 that cannot reasonably be obtained at 

24 no cost. 
39

HR 2086 RFS 

1 ‘‘(ii) No more than $1,000,000 may 

2 be expended under this section each fiscal 

3 year on creative services, except that the 

4 Director may expend up to $2,000,000 in 

5 a fiscal year on creative services to meet 

6 urgent needs of the media campaign with 

7 advance approval from the Committee on 

8 Appropriations of the House of Represent9 atives and of the Senate upon a showing of 

10 the circumstances causing such urgent 

11 needs of the media campaign. 

12 ‘‘(B) TESTING AND EVALUATION OF AD13 VERTISING.—In using amounts for testing and 

14 evaluation of advertising under paragraph 

15 (1)(D), the Director shall test all advertise16 ments prior to use in the media campaign to 

17 ensure that the advertisements are effective and 

18 meet industry-accepted standards. The Director 

19 may waive this requirement for advertisements 

20 using no more than 10 percent of the purchase 

21 of advertising time purchased under this section 

22 in an fiscal year and no more than 10 percent 

23 of the advertising space purchased under this 

24 section in a fiscal year, if the advertisements re25 spond to emergent and time-sensitive campaign 
40

HR 2086 RFS 

1 needs or the advertisements will not be widely 

2 utilized in the media campaign. 

3 ‘‘(C) EVALUATION OF EFFECTIVENESS OF

4 MEDIA CAMPAIGN.—In using amounts for the 

5 evaluation of the effectiveness of the media 

6 campaign under paragraph (1)(E), the Director 

7 shall—

8 ‘‘(i) designate an independent entity 

9 to evaluate annually the effectiveness of 

10 the national media campaign based on 

11 data from—

12 ‘‘(I) the ‘Monitoring the Future 

13 Study’ published by the Department 

14 of Health and Human Services; 

15 ‘‘(II) the Attitude Tracking 

16 Study published by the Partnership 

17 for a Drug Free America; 

18 ‘‘(III) the National Household 

19 Survey on Drug Abuse; and 

20 ‘‘(IV) other relevant studies or 

21 publications, as determined by the Di22 rector, including tracking and evalua23 tion data collected according to mar24 keting and advertising industry stand25 ards; and 
41

HR 2086 RFS 

1 ‘‘(ii) ensure that the effectiveness of 

2 the media campaign is evaluated in a man3 ner that enables consideration of whether 

4 the media campaign has contributed to re5 duction of illicit drug use among youth and 

6 such other measures of evaluation as the 

7 Director determines are appropriate. 

8 ‘‘(3) PURCHASE OF ADVERTISING TIME AND

9 SPACE.—For each fiscal year, not less than 77 per10 cent of the amounts appropriated under this section 

11 shall be used for the purchase of advertising time 

12 and space for the media campaign, subject to the 

13 following exceptions: 

14 ‘‘(A) In any fiscal year for which less than 

15 $125,000,000 is appropriated for the media 

16 campaign, not less than 82 percent of the 

17 amounts appropriated under this section shall 

18 be used for the purchase of advertising time 

19 and space for the media campaign. 

20 ‘‘(B) In any fiscal year for which more 

21 than $195,000,000 is appropriated under this 

22 section, not less than 72 percent shall be used 

23 for advertising production costs and the pur24 chase of advertising time and space for the 

25 media campaign. 
42

HR 2086 RFS 

1 ‘‘(c) ADVERTISING.—In carrying out this section, the 

2 Director shall devote sufficient funds to the advertising 

3 portion of the national media campaign to meet the goals 

4 of the campaign. 

5 ‘‘(d) PROHIBITIONS.—None of the amounts made 

6 available under subsection (b) may be obligated or ex7 pended for any of the following: 

8 ‘‘(1) To supplant current antidrug community9 based coalitions. 

10 ‘‘(2) To supplant pro bono public service time 

11 donated by national and local broadcasting networks 

12 for other public service campaigns. 

13 ‘‘(3) For partisan political purposes, or express 

14 advocacy in support of or to defeat any clearly iden15 tified candidate, clearly identified ballot initiative, or 

16 clearly identified legislative or regulatory proposal. 

17 ‘‘(4) To fund advertising that features any 

18 elected officials, persons seeking elected office, cabi19 net level officials, or other Federal officials employed 

20 pursuant to section 213 of Schedule C of title 5, 

21 Code of Federal Regulations. 

22 ‘‘(5) To fund advertising that does not contain 

23 a primary message intended to reduce or prevent il24 licit drug use. 
43

HR 2086 RFS 

1 ‘‘(6) To fund advertising containing a primary 

2 message intended to promote support for the media 

3 campaign or private sector contributions to the 

4 media campaign. 

5 ‘‘(e) MATCHING REQUIREMENT.—

6 ‘‘(1) IN GENERAL.—Amounts made available 

7 under subsection (b) shall be matched by an equal 

8 amount of non-Federal funds for the media cam9 paign, or be matched with in-kind contributions of 

10 the same value. 

11 ‘‘(2) NO-COST MATCH ADVERTISING DIRECT RE12 LATIONSHIP REQUIREMENT.—The Director shall en13 sure that at least 70 percent of no-cost match adver14 tising provided directly relates to substance abuse 

15 prevention consistent with the specific purposes of 

16 the media campaign, except that in any fiscal year 

17 in which less than $125,000,000 is appropriated to 

18 the media campaign, the Director shall ensure that 

19 at least 85 percent of no-cost match advertising di20 rectly relates to substance abuse prevention con21 sistent with the specific purposes of the media cam22 paign. 

23 ‘‘(3) NO-COST MATCH ADVERTISING NOT DI24 RECTLY RELATED.—The Director shall ensure that 

25 no-cost match advertising that does not directly re-
44

HR 2086 RFS 

1 late to substance abuse prevention includes a clear 

2 antidrug message. Such message is not required to 

3 be the primary message of the match advertising. 

4 ‘‘(f) FINANCIAL AND PERFORMANCE ACCOUNT5 ABILITY.—The Director shall cause to be performed—

6 ‘‘(1) audits and reviews of costs of the media 

7 campaign pursuant to section 304C of the Federal 

8 Property and Administrative Services Act of 1949 

9 (41 U.S.C. 254d); and 

10 ‘‘(2) an audit of the cost of the media campaign 

11 described in section 306 of such Act (41 U.S.C. 

12 256). 

13 ‘‘(g) STRATEGIC GUIDANCE AND DONATIONS.—The 

14 Partnership for a Drug Free America shall serve as the 

15 primary outside strategic advisor to the media campaign 

16 and be responsible for coordinating donations of creative 

17 and other services to the campaign, except with respect 

18 to advertising created using funds permitted in subsection 

19 (b). The Director shall inform the Partnership for a Drug 

20 Free America of the strategic goals of the campaign and 

21 consider advice from the Partnership for a Drug Free 

22 America on media campaign strategy. 

23 ‘‘(h) REPORT TO CONGRESS.—The Director shall 

24 submit on an annual basis a report to Congress that de25 scribes—
45

HR 2086 RFS 

1 ‘‘(1) the strategy of the media campaign and 

2 whether specific objectives of the media campaign 

3 were accomplished; 

4 ‘‘(2) steps taken to ensure that the media cam5 paign operates in an effective and efficient manner 

6 consistent with the overall strategy and focus of the 

7 media campaign; 

8 ‘‘(3) plans to purchase advertising time and 

9 space; 

10 ‘‘(4) policies and practices implemented to en11 sure that Federal funds are used responsibly to pur12 chase advertising time and space and eliminate the 

13 potential for waste, fraud, and abuse; and 

14 ‘‘(5) all contracts entered into with a corpora15 tion, partnership, or individual working on behalf of 

16 the media campaign. 

17 ‘‘(i) LOCAL TARGET REQUIREMENT.—The Director 

18 shall, to the maximum extent feasible, use amounts made 

19 available under this section for media that focuses on, or 

20 includes specific information on, prevention or treatment 

21 resources for consumers within specific local areas. 

22 ‘‘(j) PREVENTION OF MARIJUANA USE.—

23 ‘‘(1) FINDINGS.—The Congress finds the fol24 lowing: 
46

HR 2086 RFS 

1 ‘‘(A) 60 percent of adolescent admissions 

2 for drug treatment are based on marijuana use. 

3 ‘‘(B) Potency levels of contemporary mari4 juana, particularly hydroponically grown mari5 juana, are significantly higher than in the past, 

6 rising from under 1 percent of THC in the mid7 1970s to as high as 30 percent today. 

8 ‘‘(C) Contemporary research has dem9 onstrated that youths smoking marijuana early 

10 in life may be up to five times more likely to 

11 use hard drugs. 

12 ‘‘(D) Contemporary research has dem13 onstrated clear detrimental effects in adolescent 

14 educational achievement resulting from mari15 juana use. 

16 ‘‘(E) Contemporary research has dem17 onstrated clear detrimental effects in adolescent 

18 brain development resulting from marijuana 

19 use. 

20 ‘‘(F) An estimated 9,000,000 Americans a 

21 year drive while under the influence of illegal 

22 drugs, including marijuana. 

23 ‘‘(G) Marijuana smoke contains 50 to 70 

24 percent more of certain cancer causing chemi25 cals than tobacco smoke. 
47

HR 2086 RFS 

1 ‘‘(H) Teens who use marijuana are up to 

2 four times more likely to have a teen pregnancy 

3 than teens who have not. 

4 ‘‘(I) Federal law enforcement agencies 

5 have identified clear links suggesting that trade 

6 in hydroponic marijuana facilitates trade by 

7 criminal organizations in hard drugs, including 

8 heroin. 

9 ‘‘(J) Federal law enforcement agencies 

10 have identified possible links between trade in 

11 marijuana and financing for terrorist organiza12 tions. 

13 ‘‘(2) EMPHASIS ON PREVENTION OF YOUTH

14 MARIJUANA USE.—In conducting advertising and ac15 tivities otherwise authorized under this section, the 

16 Director may emphasize prevention of youth mari17 juana use. 

18 ‘‘(k) AUTHORIZATION OF APPROPRIATIONS.—There 

19 is authorized to be appropriated to the Office to carry out 

20 this section, $195,000,000 for each of fiscal years 2004 

21 and 2005 and $210,000,000 for each of fiscal years 2006 

22 through 2008.’’. 

23 (b) REPEAL OF SUPERSEDED PROVISIONS.—The 

24 Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 

25 et seq.) is repealed. 
48

HR 2086 RFS 

1 SEC. 11. AUTHORIZATION OF APPROPRIATIONS. 

2 Section 714 (21 U.S.C. 1711) is amended—

3 (1) by striking ‘‘title,’’ and inserting ‘‘title, ex4 cept activities for which amounts are otherwise spe5 cifically authorized by this title,’’; and 

6 (2) by striking ‘‘1999 through 2003’’ and in7 serting ‘‘2004 through 2008’’. 

8 SEC. 12. EXTENSION OF TERMINATION DATE. 

9 Section 715(a) is amended by striking ‘‘September 

10 30, 2003, this title and the amendments made by this title 

11 are repealed’’ and inserting ‘‘September 30, 2008, this 

12 title is repealed’’.

Passed the House of Representatives September 30, 

2003. 

Attest: JEFF TRANDAHL, 

Clerk.